HF
NEO icon

HRT Financial’s NeoGenomics NEO Stock Holding History

HRT Financial’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11,285
Closed -$138K – 2827
2023
Q3 		$138K Sell
11,285
-6,424
-36% -$95.5K ﹤0.01% 1912
2023
Q2 		$284K Sell
17,709
-175,944
-91% -$2.9M ﹤0.01% 1657
2023
Q1 		$3.37M Buy
+193,653
New +$2.76M 0.04% 384
2022
Q1 		– Sell
-53,770
Closed -$1.83M – 3599
2021
Q4 		$1.83M Buy
+53,770
New +$2.11M 0.01% 714

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

HRT Financial's NEO Position: Q4 2023 in Review

HRT Financial sold out of NeoGenomics (NEO) in Q4 2023, closing a stake of 11,285 shares — an estimated $138K sold.

HRT Financial first reported a position in NEO in Q4 2021 and held it in 4 quarters. The position peaked at $3.37M in Q1 2023. 287 funds tracked by Wall St. Rank hold NEO as of Q4 2023.

  • HRT Financial reported no remaining NeoGenomics position as of Q4 2023 after selling out during the quarter.
  • HRT Financial sold 11,285 NeoGenomics shares in Q4 2023, an estimated $138K.
  • HRT Financial first reported a position in NeoGenomics in Q4 2021 and held it in 4 quarters.
  • HRT Financial's NeoGenomics position peaked at $3.37M in Q1 2023.
  • 287 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2023.

Based on HRT Financial's 13F filing for Q4 2023, filed 9 Feb 2024.